Načítá se...
Antibiotic treatment for Helicobacter pylori: Is the end coming?
Infection with the Gram-negative pathogen Helicobacter pylori (H. pylori) has been associated with gastro-duodenal disease and the importance of H. pylori eradication is underscored by its designation as a group I carcinogen. The standard triple therapy consists of a proton pump inhibitor, amoxicill...
Uloženo v:
| Vydáno v: | World J Gastrointest Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635158/ https://ncbi.nlm.nih.gov/pubmed/26558152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v6.i4.183 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|